NeuroPanels: Neuro-oncology Case Discussion
Course Description
Our host, José Posas, MD, FAAN, is joined by Nimish Mohile, MD, FAAN, Lauren Schaff, MD, Eunji Yim, MD, and John Fortunato, MD to take us through two tumor cases. They will first discuss a low grade IDH-mutant glioma case. Next, they will move on to discuss a case of a patient presenting with a high grade glioblastoma. Following the two cases, there will be 25 minutes of panel discussion and audience Q&A.
Learning Objectives
As a result of this video the learner will be able to:
- Understand the role of IDH inhibitors in the management of IDH-mutated gliomas.
- Review diagnostic workup for glioblastoma and proposed treatment
Date of Release
Tuesday, August 22nd - 06:00 PM - 07:00 PM CT
Confidentiality of Data
All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete
Terms of Use.
ACCREDITATION
The American Academy of Neurology Institute (AANI), a subsidiary of the American Academy of Neurology (AAN), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
The American Academy of Neurology Institute (AANI) designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
UNLABELED USE DISCLOSURE
The AANI requires all NeuroPanels presenters to disclose if a therapy/product is not labeled for the use being discussed or if the therapy/product is still investigational.
Faculty & Disclosures
HOST
JOSE POSAS, III, MD
Attending Physician in Neurology
Neurology Residency Program Director, Ochsner Clinic Foundation
New Orleans, LA
*Dr. Posas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Peerlink Medical. Dr. Posas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Elite Medical Experts.
PANELISTS & DISCLOSURES
Nimish Mohile, MD, FAAN
Professor of Neuro-oncology
University of Rochester Medical Center
Rochester, NY
*Dr. Mohile has nothing to disclose.
Lauren R. Schaff, MD
Professor of Neuro-oncology
Memorial Sloan Kettering Cancer Center
New York, NY
*Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals. An immediate family member of Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MichieHamlett Attorneys at Law. The institution of Dr. Schaff has received research support from BTG, plc. The institution of Dr. Schaff has received research support from Merck.
MODERATORS
Eunji Yim, MD
Neuro-oncology Fellow
New York Presbyterian Hospital
New York, NY
*Dr. Yim has nothing to disclose.
John Fortunato, MD
Neuro-oncology Fellow
Memorial Sloan Kettering
New York, NY
*Dr. Fortunato has nothing to disclose.
NeuroPanels Staff
Xiaoyu Sun
Associate Director, eLearning
Minneapolis, MN
*Ms. Sun has nothing to disclose.
Bobby Rook
Manager, eLearning
Minneapolis, MN
*Mr. Rook has nothing to disclose.
Zachary Cramer
eLearning Program Manager
Minneapolis, MN
*Mr. Cramer has nothing to disclose.